Bryan Burmeister

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

Bryan Burmeister, B. Mark Smithers, Val Gebski et al. · The Lancet Oncology · 2005 · 928 citations

Surgical Oncology, Resectable Cancer, Esophagus +10

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

Samuel Y. Ngan, Bryan Burmeister, Richard Fisher et al. · Journal of Clinical Oncology · 2012 · 908 citations

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial

Bryan Burmeister, Janine Thomas, Elizabeth Burmeister et al. · European Journal of Cancer · 2010 · 325 citations

Preoperative Chemotherapy, Surgical Oncology, Esophageal Cancer +8

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial

Bryan Burmeister, Michael A. Henderson, Jill Ainslie et al. · The Lancet Oncology · 2012 · 291 citations

Surgical Oncology, Radiation Therapy, Lymph-node Field Relapse +7

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial

Michael A. Henderson, Bryan Burmeister, Jill Ainslie et al. · The Lancet Oncology · 2015 · 219 citations

Surgical Oncology, Health Sciences, Radiation Therapy +9